Protego Ventures

Defense & National Security Fund Dual-Use Technology Founded 2024

Last updated: May 7, 2026

Protego Ventures is Israel's first defense-exclusive venture capital fund (founded 2024), investing across early-growth defense technology including autonomous systems, sensors, AI/ML, and advanced electronics. The $200M fund targets U.S. institutional capital for Israeli defense startups.

Visit Website

Company Overview

Protego Ventures, founded in 2024 by Lital Leshem and Lee Moser, represents the first Israeli venture capital fund exclusively dedicated to defense technology. The fund raised $70 million in investment commitments within two weeks of launch and targets $200 million, exceeding its original $150 million goal. This oversubscription reflects significant institutional appetite from U.S. and international investors for Israel-based defense tech opportunities, particularly defense companies addressing NATO requirements, U.S. Pacific theater concerns, and emerging cyber/autonomous threats.

Israel's defense technology sector has generated some of the world's most successful military-grade companies, from missiles and radar to cybersecurity and intelligence systems. Protego Ventures is positioned as an institutionalized gateway to this ecosystem. The fund's initial portfolio includes a $5 million investment in Xtend, a drone/UAS company, and it is actively evaluating dozens of defense startups across sensors, autonomous systems, AI/ML target identification, communications, electronic warfare, and drone technologies. The fund's deployment strategy focuses on growth-stage Israeli defense companies with credible defense ministry traction and export potential to allied militaries.

The founding team brings substantial credentials in both defense entrepreneurship and U.S. government/institutional relationships. Leshem co-founded Carbyne, an emergency response technology company that raised $140 million and operates across emergency dispatch and situational awareness. Moser is a former founding partner at AnD Ventures and served as Chief of Staff to Michael Oren at the Israeli Embassy in Washington, providing direct relationships with U.S. institutional capital and defense procurement channels. This combination positions the fund to bridge Israeli innovation with U.S. Department of Defense (DoD), allied militaries, and institutional capital.

Structurally, Protego operates as a traditional VC fund, not a product or technology company. However, its strategic significance lies in three dimensions: (1) it signals institutional confidence in Israeli defense tech as an asset class suitable for systematic capital deployment, (2) it provides dealflow visibility into early-stage Israeli defense innovations before broader market awareness, and (3) it creates a pathway for Israeli defense startups to access U.S. institutional capital and defense procurement relationships. Fund performance will be measured on portfolio company outcomes—successful exits, acquisition by integrators or foreign governments, or IPOs in the aerospace/defense category.

Dual-Use Assessment

Military & Commercial Applications

Protego Ventures itself is a capital vehicle, not a dual-use technology. However, its portfolio companies operate in dual-use defense sectors: autonomous systems (commercial drones and defense UAS), AI/ML (commercial computer vision and defense target ID), sensors (civil and military applications), and communications (emergency and defense use). Fund success depends on portfolio company technology maturity and dual-use defensibility.

Strategic Fit Assessment

Protego Ventures is not directly actionable as a target—it is a VC fund managed by third parties. However, it serves as a key strategic indicator and access vector. for strategic readers or acquirers seeking exposure to Israeli defense tech, Protego provides: (1) dealflow visibility into early-stage Israeli defense companies before public market awareness; (2) validation that U.S. institutional capital considers Israeli defense tech a legitimate, professional asset class worthy of systematic capital deployment; (3) potential secondary market access if fund performance justifies LP follow-on rounds or secondary sales; (4) pattern recognition on Israeli defense technology trends, customer traction models, and commercialization timelines. The fund's success will depend on portfolio company exits (acquisition by defense primes, foreign government procurement, or aerospace IPOs), acquisition multiples relative to software/general deep-tech peers, and revenue diversification across U.S. DoD, allied militaries (NATO, AUKUS), and integrators. Fund economics remain opaque, but typical Israeli defense software exit multiples (3-8x revenue) and hardware exits (1-3x revenue) suggest $70M deployed capital could generate $500M+ in return IF 2-3 portfolio companies achieve >$100M revenue or strategic acquisition.

Strategic Value to U.S.-Israel Alliance

Protego Ventures is a barometer of institutional confidence in Israeli defense innovation and provides systematic access to early-stage Israeli defense startups before broader market awareness. Its formation accelerates cross-border capital flow from U.S. institutional investors to Israeli defense founders, reducing friction for Israeli startups seeking U.S. military and allied customer traction. The fund indirectly validates the commercial and strategic viability of Israeli defense technologies by subjecting them to rigorous VC due diligence. For strategic investors or acquirers in aerospace, defense, or security, Protego's portfolio companies represent potential acquisition targets or joint venture partners with credible defense ministry validation and export pathways.

Key Technologies

  • Defense technology diligence thesis
  • Sensors and detection systems
  • AI/ML for defense applications
  • Autonomous systems and drones
  • Defense electronics and communications

Use Cases & Applications

  • Defense startup capital formation and institutional scaling
  • Israeli autonomous systems (drones, UAS) commercialization to allied militaries
  • AI/ML-driven target identification and sensor fusion for defense applications
  • Dual-use sensors and detection technologies (civil and military markets)
  • Defense electronics and communications systems (encrypted, hardened)
  • Cross-border capital and customer introduction for Israeli defense founders
  • U.S. DoD and allied military procurement pathway acceleration
  • Defense acquisition target identification for integrators and primes

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

  • Official website Primary public reference for company identity, positioning, and current web presence.
  • Profile update timestamp Last updated in the Claw & Talon database on May 7, 2026.

Investor Lens

What this entry is

Fund

Why it may matter

Protego Ventures may matter as a Defense & National Security entry with fund/manager research for Israeli technology research.

How an independent investor should read this

Fund/manager research. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status
  • Verify technical claims
  • Verify regulatory/export-control issues

Main investor questions

  • What fund vehicle, manager track record, reserve strategy, fees, carry, and reporting terms would actually be evaluated?
  • Does the manager have differentiated sourcing and repeatable support for Israeli technology companies?
  • Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies Protego Ventures's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
  • What export-control, supply-chain, manufacturing, or classified-market constraints could affect U.S. and allied adoption?
  • Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?

Related sector

See the Defense & National Security sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.